PRIVI SPECIALITY CHE Latest Share Price (PRIVISCL)
TODAY IN ONE LINE
PRIVISCL rose 1.7% on average volume, outperforming Nifty's -0.3% move.
With a market cap of ₹13,859.64 Cr., it trades at a P/E of 40.00. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
PRIVI SPECIALITY CHE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 40.9% YoY
- ●High Capital EfficiencyROCE of 19.1% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 24.9%
- ●Healthy Operating MarginsOPM is structurally strong at 22.2%
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Rising Receivables vs SalesReceivables grew 23.0% outpacing sales growth of 19.9%
Latest PRIVI SPECIALITY CHE News
What changed recently?
Recent events, corporate actions, and announcements.
PRIVI SPECIALITY CHE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for PRIVI SPECIALITY CHE, framed against the sector median so the premium or discount is obvious at a glance.
PRIVI SPECIALITY CHE trades at a P/E of 40.00× and P/B of 9.81×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
PRIVI SPECIALITY CHE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for PRIVI SPECIALITY CHE — derived from the latest tape, not yesterday's close.
PRIVI SPECIALITY CHE last traded at ₹3,556.1 with an intraday range of ₹3,418–₹3,570.5 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹3556.10| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 3916.73 | +360.63 | +10.14% |
| R3 | 3764.23 | +208.13 | +5.85% |
| R2 | 3667.37 | +111.27 | +3.13% |
| R1 | 3611.73 | +55.63 | +1.56% |
| PIVOT | 3514.87 | -41.23 | -1.16% |
| CURRENT | 3556.10 | — | — |
| S1 | 3459.23 | -96.87 | -2.72% |
| S2 | 3362.37 | -193.73 | -5.45% |
| S3 | 3306.73 | -249.37 | -7.01% |
| S4 | 3154.23 | -401.87 | -11.30% |
PRIVISCL is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹3418–₹3464.1
Trading Above opening range, showing Bullishness
PRIVI SPECIALITY CHE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for PRIVI SPECIALITY CHE — consolidated or standalone — with margins, YoY growth and key ratios inline.
PRIVI SPECIALITY CHE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹13,859.64 Cr. and reported EPS of ₹21.56.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 2,101 | 2,564 ▲ 22.0% |
| Sales Growth YoY %Derived | 19.91% | 22.01% |
| Other Income | 21 | 19 ▼ 6.8% |
| Total Income | 2,122 | 2,583 ▲ 21.7% |
| 1,131 | 1,317 ▲ 16.4% | |
| Gross ProfitDerived | 970 | 1,247 ▲ 28.6% |
| Gross Margin %Derived | 46.15% | 48.62% |
| 516 | 600 ▲ 16.3% | |
| EBITDA (Operating Profit)Derived | 454 | 646 ▲ 42.5% |
| OPM %Derived | 21.58% | 25.21% |
| 220 | 226 ▲ 2.8% | |
| Profit Before Tax (PBT) | 255 | 440 ▲ 72.8% |
| 70 | 123 ▲ 76.3% | |
| Effective Tax %Derived | 27.41% | 27.97% |
| Total Profit for Period | 185 | 317 ▲ 71.4% |
| Less: Non-controlling Interests | — | — |
| Net Profit (Owner's PAT)Derived | 185 | 317 ▲ 71.4% |
| Net Profit Margin %Derived | 8.79% | 12.35% |
| PAT Growth YoY %Derived | 93.60% | 71.43% |
| Earnings Per Share (EPS ₹) | 47.30 | 81.08 ▲ 71.4% |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -0 | 1 ▲ 798.0% |
| Total Expenses (incl. D&A & Interest) | 1,867 | 2,143 ▲ 14.8% |
| Material Cost % of RevenueDerived | 55.78% | 52.88% |
| Employee Cost % of RevenueDerived | 4.12% | 4.47% |
| Other Cost % of RevenueDerived | 20.45% | 18.94% |
| Interest Coverage (x)Derived | 3.66x | 6.13x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 1,040 | 1,341 ▲ 29.0% | 1,631 ▲ 21.6% | 1,277 ▼ 21.7% | 1,404 ▲ 10.0% | 1,608 ▲ 14.5% | 1,752 ▲ 9.0% | 2,101 ▲ 19.9% | 2,564 ▲ 22.0% | |
| Sales Growth YoY %Derived | — | 29.01% | 21.59% | -21.71% | 9.96% | 14.54% | 8.98% | 19.91% | 22.01% | |
| Other Income | 16 | 6 ▼ 64.4% | 27 ▲ 368.3% | 20 ▼ 25.2% | 32 ▲ 62.3% | 21 ▼ 33.9% | 26 ▲ 22.8% | 21 ▼ 21.5% | 19 ▼ 6.8% | |
| Total Income | 1,056 | 1,347 ▲ 27.6% | 1,657 ▲ 23.1% | 1,297 ▼ 21.8% | 1,436 ▲ 10.8% | 1,629 ▲ 13.4% | 1,779 ▲ 9.2% | 2,122 ▲ 19.3% | 2,583 ▲ 21.7% | |
663 | 827 ▲ 24.8% | 1,008 ▲ 21.9% | 751 ▼ 25.5% | 831 ▲ 10.6% | 961 ▲ 15.6% | 1,009 ▲ 5.0% | 1,131 ▲ 12.1% | 1,317 ▲ 16.4% | ||
| Gross ProfitDerived | 377 | 514 ▲ 36.4% | 623 ▲ 21.1% | 525 ▼ 15.6% | 573 ▲ 9.0% | 647 ▲ 12.9% | 743 ▲ 14.8% | 970 ▲ 30.5% | 1,247 ▲ 28.6% | |
| Gross Margin %Derived | 36.26% | 38.34% | 38.20% | 41.16% | 40.80% | 40.23% | 42.39% | 46.15% | 48.62% | |
247 | 301 ▲ 22.2% | 355 ▲ 17.7% | 318 ▼ 10.4% | 379 ▲ 19.2% | 461 ▲ 21.6% | 418 ▼ 9.3% | 516 ▲ 23.5% | 600 ▲ 16.3% | ||
| EBITDA (Operating Profit)Derived | 130 | 213 ▲ 63.3% | 268 ▲ 26.0% | 208 ▼ 22.5% | 194 ▼ 6.6% | 186 ▼ 4.1% | 325 ▲ 74.8% | 454 ▲ 39.6% | 646 ▲ 42.5% | |
| OPM %Derived | 12.53% | 15.86% | 16.43% | 16.26% | 13.81% | 11.56% | 18.55% | 21.58% | 25.21% | |
67 | 85 ▲ 26.3% | 143 ▲ 68.9% | 116 ▼ 19.5% | 104 ▼ 9.9% | 176 ▲ 69.4% | 221 ▲ 25.6% | 220 ▼ 0.8% | 226 ▲ 2.8% | ||
| Profit Before Tax (PBT) | 79 | 152 ▲ 92.0% | 231 ▲ 52.6% | 158 ▼ 31.6% | 133 ▼ 16.1% | 31 ▼ 76.6% | 130 ▲ 318.5% | 255 ▲ 95.9% | 440 ▲ 72.8% | |
26 | 57 ▲ 123.7% | 55 ▼ 4.1% | 41 ▼ 24.8% | 35 ▼ 14.4% | 10 ▼ 72.4% | 34 ▲ 253.1% | 70 ▲ 102.4% | 123 ▲ 76.3% | ||
| Effective Tax %Derived | 32.45% | 37.82% | 23.76% | 26.12% | 26.65% | 31.46% | 26.54% | 27.41% | 27.97% | |
| Total Profit for Period | 53 | 94 ▲ 76.7% | 176 ▲ 87.1% | 117 ▼ 33.7% | 97 ▼ 16.7% | 21 ▼ 78.1% | 95 ▲ 348.5% | 185 ▲ 93.6% | 317 ▲ 71.4% | |
| Less: Non-controlling Interests | — | — | — | — | — | -1 | — ▲ 100.0% | — | — | |
| Net Profit (Owner's PAT)Derived | 53 | 94 ▲ 76.7% | 176 ▲ 87.1% | 117 ▼ 33.7% | 97 ▼ 16.7% | 22 ▼ 77.2% | 95 ▲ 329.6% | 185 ▲ 93.6% | 317 ▲ 71.4% | |
| Net Profit Margin %Derived | 5.13% | 7.03% | 10.81% | 9.16% | 6.94% | 1.38% | 5.45% | 8.79% | 12.35% | |
| PAT Growth YoY %Derived | — | 76.69% | 87.10% | -33.70% | -16.70% | -77.19% | 329.58% | 93.60% | 71.43% | |
| Earnings Per Share (EPS ₹) | 14.18 | 24.13 ▲ 70.2% | 45.14 ▲ 87.1% | 29.93 ▼ 33.7% | 24.93 ▼ 16.7% | 5.69 ▼ 77.2% | 24.43 ▲ 329.3% | 47.30 ▲ 93.6% | 81.08 ▲ 71.4% | |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 3.9% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 0 | -0 ▼ 528.3% | 1 ▲ 433.5% | -1 ▼ 207.7% | 0 ▲ 130.4% | 2 ▲ 1273.0% | 0 ▼ 82.8% | -0 ▼ 134.6% | 1 ▲ 798.0% | |
| Total Expenses (incl. D&A & Interest) | 977 | 1,195 ▲ 22.4% | 1,426 ▲ 19.3% | 1,138 ▼ 20.2% | 1,303 ▲ 14.5% | 1,598 ▲ 22.6% | 1,649 ▲ 3.2% | 1,867 ▲ 13.3% | 2,143 ▲ 14.8% | |
| Material Cost % of RevenueDerived | 60.92% | 68.95% | 62.40% | 61.24% | 71.50% | 71.04% | 54.47% | 55.78% | 52.88% | |
| Employee Cost % of RevenueDerived | 5.46% | 5.31% | 4.94% | 5.47% | 5.46% | 4.96% | 4.15% | 4.12% | 4.47% | |
| Other Cost % of RevenueDerived | 18.27% | 17.17% | 16.82% | 19.43% | 21.53% | 23.71% | 19.70% | 20.45% | 18.94% | |
| Interest Coverage (x)Derived | 3.63x | 5.72x | 5.04x | 6.38x | 4.94x | 1.14x | 2.06x | 3.66x | 6.13x |
PRIVI SPECIALITY CHE segment analysis : revenue and profit mix.
Disclosed business segments at PRIVI SPECIALITY CHE with their share of revenue and profit, switchable between consolidated and standalone reporting.
PRIVI SPECIALITY CHE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for PRIVI SPECIALITY CHE.
Our AI distills the core fundamental drivers supporting PRIVI SPECIALITY CHE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
PRIVI SPECIALITY CHE's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 52 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 20% would indicate weaker capital compounding.
PRIVI SPECIALITY CHE peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — PRIVI SPECIALITY CHE is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
PRIVI SPECIALITY CHE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for PRIVI SPECIALITY CHE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
PRIVI SPECIALITY CHE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for PRIVI SPECIALITY CHE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in PRIVI SPECIALITY CHE stood at 58.2% of traded volume, against a 20-day average of 64.4%.
PRIVI SPECIALITY CHE announcements: results, concalls, ratings, M&A.
Filings PRIVI SPECIALITY CHE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
PRIVI SPECIALITY CHE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 137 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Privi Speciality Chemicals Limited has informed the Exchange about Schedule of Analyst/ Institutional Investor Meeting to be held on August 18,2026.
Shareholders meeting
Privi Speciality Chemicals Limited has informed the Exchange regarding voting results of Annual General Meeting held on August 07, 2026
Shareholders meeting
Privi Speciality Chemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 07, 2026
Shareholders meeting
Privi Speciality Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 07, 2026
Analysts/Institutional Investor Meet/Con. Call Updates
Privi Speciality Chemicals Limited has informed the Exchange about Transcript of Earning Call held on Friday 31 July 2026.
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
PRIVI SPECIALITY CHE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue PRIVI SPECIALITY CHE has declared, sequenced by announce and record date.
PRIVI SPECIALITY CHE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About PRIVI SPECIALITY CHE: business, sector, key facts.
What PRIVI SPECIALITY CHE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
PRIVI SPECIALITY CHE operates in the Specialty Chemicals industry under the Chemicals sector, listed as NSE: PRIVISCL, BSE: 530117.
Privi Speciality Chemicals Limited (formerly Fairchem Speciality Limited) is a global manufacturer, supplier, and exporter of aroma and fragrance chemicals. Established in 1985 and headquartered in Mumbai, India, the company operates across a wide range of international markets including North America, Asia, the Middle East, Africa, Europe, South America, and the United Kingdom.
Their product portfolio encompasses a broad spectrum of aroma and fragrance chemicals, categorized into several key groups. These include acetates, dihydromyrcenol, ionones, nitriles, sandalwood derivatives, and other specialty chemicals. They offer both bulk aroma chemicals and a comprehensive selection of individual aroma chemicals, with a particularly extensive range of terpenes and terpene derivatives.
The company's detailed catalog includes a wide array of specific aroma chemicals, such as alpha damascone, alpha ionone, alpha terpenyl acetate, various forms of amber, beta iso damascol, different grades of BI, carene, cedar ketol, citronellal, citronellyl acetate, citronellyl nitrile, dipentene, various turpentine oils, dihydro myrcenol, dihydromyrcene, gamma methyl ionone, gamma terpenyl acetate, geraniol, geranyl acetate, Indian sandal core, various ionones, iso boronyl acetate, l-limonene, methyl ionone, nerol, neryl acetate, nimberol, OTBCHA, pine oil, prionyl, PTBCHA, rose oxide, multiple terpeniols, terpinolene, and several sandal-based products. Further expanding their offerings, they also supply cineol, trimethyl cyclohexyl methanol, cyclamen aldehyde, indomeran, floravane, ambo woody extreme, camphor, and iso berneol commercial.
In summary, Privi Speciality Chemicals Limited holds a significant position in the global aroma and fragrance chemical market, providing a diverse and extensive range of products to a global clientele. Their long history and international reach demonstrate their established presence and continued success within the industry.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AARTI INDUSTRIES (AARTIIND) Share PricePeer
- AARTISURF (AARTISURF) Share PricePeer
- ARCHEAN CHEMICAL IND (ACI) Share PricePeer
- AETHER INDUSTRIES (AETHER) Share PricePeer
- ALKALI METALS (ALKALI) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about PRIVI SPECIALITY CHE (PRIVISCL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of PRIVI SPECIALITY CHE (PRIVISCL)?
The current share price of PRIVI SPECIALITY CHE (PRIVISCL) is ₹3,556.10. Today, the stock has gained by ₹60.50 (1.73%), trading in a range of ₹3,418.00 to ₹3,570.50. The stock opened at ₹3,437.90 with a trading volume of 1,07,650 shares.
02Is PRIVI SPECIALITY CHE stock a good investment for long-term?
PRIVI SPECIALITY CHE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹13,859.64 Cr., P/E ratio of 40, ROE of 24.86%, and ROCE of 19.11%. The dividend yield stands at 0.28%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of PRIVI SPECIALITY CHE stock?
The 52-week high price of PRIVI SPECIALITY CHE (PRIVISCL) is ₹3,785.30, while the 52-week low is ₹2,299.80. Currently trading at ₹3,556.10, the stock is 54.63% above its 52-week low and 6.06% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy PRIVI SPECIALITY CHE stock at the current price?
Whether to buy PRIVI SPECIALITY CHE stock at ₹3,556.10 depends on multiple factors. The stock is currently trading with a P/E ratio of 40 and P/B ratio of 9.81. Today's performance shows a gain of 1.73%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of PRIVI SPECIALITY CHE and when is the next dividend?
PRIVI SPECIALITY CHE offers a dividend yield of 0.28%, which means for every ₹100 invested at the current price of ₹3,556.10, you can expect to receive approximately ₹0.28 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of PRIVI SPECIALITY CHE?
PRIVI SPECIALITY CHE's key financial metrics include: P/E Ratio: 40, P/B Ratio: 9.81, ROE: 24.86%, ROCE: 19.11%, Dividend Yield: 0.28%, EPS: ₹21.56, Book Value: ₹368.79, and Debt-to-Equity: 0.5. The company's market cap stands at ₹13,859.64 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is PRIVI SPECIALITY CHE stock performing today in the market?
PRIVI SPECIALITY CHE stock opened at ₹3,437.90 and is currently trading at ₹3,556.10, showing a gain of ₹60.50 (1.73%). The intraday high is ₹3,570.50 and low is ₹3,418.00. The trading volume stands at 1,07,650 shares, indicating moderate market participation today.
08What is the P/E ratio of PRIVI SPECIALITY CHE and what does it indicate?
PRIVI SPECIALITY CHE has a Price-to-Earnings (P/E) ratio of 40, which means investors are willing to pay 40.00 for every ₹1 of earnings. With an EPS of ₹21.56, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about PRIVI SPECIALITY CHE (PRIVISCL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.